Advertisement

The Interaction Between Nutrition and Inflammatory Stress Throughout the Life Cycle

  • Robert F. Grimble
Chapter
  • 1.2k Downloads
Part of the Nutrition and Health book series (NH)

Abstract

The human race inhabits a world in which it is surrounded by a myriad of different microorganisms—yeasts, bacteria, protozoa, and viruses. Most of these are benign, and some, such as the normal gut flora, play an important part in promoting health via the synthesis of vitamins and stimulation of normal function of gut epithelia. Approximately 0.1% of microbes in our environment have catastrophic effects if they penetrate the epithelial surfaces of the body (Bryson, 2003). History reveals many instances in which armies have been defeated and civilizations have collapsed because of encounters between humans and such microorganisms (Diamond, 1999).

Keywords

Chronic Disorder Tumor Necrosis Factor Production Inflammatory Stress Soluble Tumor Necrosis Factor Receptor Insulin Insensitivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ables, G. P., Takamatsu, D., Noma, H., El-Shazly, S., Jin, H. K., Taniguchi, T., Sekikawa, K., & Watanabe, T. (2001). The roles of Nramp1 and Tnfα genes in nitric oxide production and their effect on the growth of Salmonella typhimurium in macrophages from Nramp1 congenic and tumor necrosis factor-alpha-/-mice. Journal of Interferon Cytokine Research, 21, 53–62.CrossRefGoogle Scholar
  2. Allen, R. D. (1999). Polymorphism of the human TNF-α promoter—random variation or functional diversity? Molecular Immunolology, 36, 1017–1027.CrossRefGoogle Scholar
  3. Armitage, G. C. (2000). Periodontal infections and cardiovascular disease—how strong is the association? Oral Disease, 6, 335–350.CrossRefGoogle Scholar
  4. Arnalich, F., Garcia-Palomero, E., Lopez, J., Jiminez, M., Madero, R., Renart, J., Vazquez, J. J., & Montiel, C. (2000). Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infection and Immununity, 68, 1942–1945.CrossRefGoogle Scholar
  5. Azzi, A., Boscoboinik, D., & Marilley, D. (1995). Vitamin E: A sensor and an information transducer of the cell oxidation state. American Journal of Clinical Nutrition, 62(6 Suppl.), 1337S–1346S.Google Scholar
  6. Baggio, G., Donnazzan, S., Monti, D., & Mari, D. (1998). Lipoprotein(a) and lipoprotein profile in healthy centenarians: A reappraisal of vascular risk factors. FASEB Journal, 12, 433–437.Google Scholar
  7. Beale, R. J., Bryg, D. J., & Bihari, D. J. (1999). Immunonutrition in the critically ill: A systematic review of clinical outcome. Critical Care Medicine, 27, 2799–2805.CrossRefGoogle Scholar
  8. Bell, D. S. (2000). Inflammation, insulin resistance, infection, diabetes, and atherosclerosis. Endocrinological Practice, 6, 272–276.Google Scholar
  9. Bethin, K. E., Vogt, S. K., & Muglia, L. J. (2000). Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimula-torof the adrenal axis during immune system activation. Proceedings of the National Academy of Science USA, 97, 9317–9322.CrossRefGoogle Scholar
  10. Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M. F., Oksenberg, J., McNicholl, J., Pociot, F., Hardt, C., & D’Alfonso, S. (2001). Cytokine gene polymorphism in human disease: Online databases, supplement 1. Genes and Immunology, 2, 61–70.CrossRefGoogle Scholar
  11. Bonafe, M., Olivieri, F., & Cavallone, L. (2001). A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental to longevity. European Journal of Immunology, 31, 2357–2361.CrossRefGoogle Scholar
  12. Bonora, E., Kiechl, S., & Oberhollenzer, E. (2000). Impaired glucose tolerance, type 2 diabetes mellitus and carotid atherosclerosis: Prospective results of the Bruneck Study. Diabetologia, 43, 156–164.CrossRefGoogle Scholar
  13. Boya, P., de la Pena, A., Beloqui, O., Larrea, E., Conchillo, M., Castelruiz, Y., Civeira, M. P., & Prieto, J. (1999). Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. Journal of Hepatology, 31, 808–814.CrossRefGoogle Scholar
  14. Breitkreutz, R., Pittack, N., Nebe, C. T., Schuster, D., Brust, J., Beichert, M., Hack, V., Daniel, V., Edler, L., & Droge, W. (2000). Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials. Journal of Molecular Medicine, 78, 55–62.CrossRefGoogle Scholar
  15. Bryson, B. (2003). In A short history of nearly everything. New York: Doubleday.Google Scholar
  16. Calder, P. C. (1997). n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Annals of Nutrition and Metabolism, 41, 203–234.Google Scholar
  17. Cao, Y., Feng, Z., Hoos, A., & Klimberg, V. S. (1998). Glutamine enhances gut glutathione production. Journal of Parenteral and Enteral Nutrition, 22, 224–227.Google Scholar
  18. Caruso, C., Candore, G., Romano, G. C., Lio, D., Bonafe, M., Valensin, S., & Franceschi, C. (2001). Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data. Mechanisms of Ageing and Development, 122, 445–462.CrossRefGoogle Scholar
  19. Chambers, J. C., Eda, S., & Bassett, P. (2001). C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation, 104, 145–150.Google Scholar
  20. Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., & Dinarello, C. A. (1995). A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. Journal of Immunology, 154, 5492–5499.Google Scholar
  21. Chorazy, P. A., Schumacher, H. R., Jr., & Edlind, T. D. (1992). Glutathione peroxidase in rheumatoid arthritis: Analysis of enzyme activity and DNA polymorphism. DNA Cell Biology, 11, 221–225.Google Scholar
  22. Choi, S. S., Gatanaga, M., Granger, G. A., & Gatanaga, T. (1996). Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Cellular Immunology, 170, 178–184.CrossRefGoogle Scholar
  23. Chu, N. F., Spiegelman, D., & Hotamisligil, G. S. (2001). Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis, 157, 495–503.CrossRefGoogle Scholar
  24. Cnop, M., Landchild, M. J., & Vidal, J. (2002). The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: Distinct metabolic effects of two fat compartments. Diabetes, 51, 1005–1015.CrossRefGoogle Scholar
  25. Corry, D. B., & Tuck, M. L. (2001). Selective aspects of the insulin resistance syndrome. Current Opinion in Nephrology and Hypertension, 10, 507–514.CrossRefGoogle Scholar
  26. Debril, M. B., Renaud, J. P., Fajas, L., & Auwerx, J. (2001). The pleiotropic functions of peroxisome proliferator-activated receptor gamma. Journal of Molecular Medicine, 79, 30–47.CrossRefGoogle Scholar
  27. Denno, R., Rounds, J. D., Faris, R., Halejko, L. B., & Wilmore, D. W. (1996). Glutamine enriched TPN enhances plasma glutathione in resting state. Journal of Surgical Research, 61, 35–38.CrossRefGoogle Scholar
  28. De Rosa, S. C., Zaretsky, M. D., Dubs, J. D., Roederer, M., Anderson, M., Green, A., Mitra, D., Watanabe, N., Nakamura, H., Tjioe, I., Deresinski, S. C., Moore, W. A., Ela, S. W., Parks, D., Herzenberg, L. A., & Herzenberg, L. A. (2000). N-Acetylcysteine replenishes glutathione in HIV infection. European Journal of Clinical Investigation, 30, 915–929.CrossRefGoogle Scholar
  29. Devaraj, S., & Jialal, I. (2000). Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: The effect of alpha-tocopherol supplementation. Circulation, 102, 191–196.Google Scholar
  30. Diamond, J. (1999). In Guns, germs and steel: The fate of human societies. New York: W. W. Norton & Co.Google Scholar
  31. Dillon, G., Vita, J. A., & Leeuwenburgh, C. (1998). α-Tocopherol supplementation reduces systemic markers of oxidative damage in healthy adults. Circulation, 17S, 671I.Google Scholar
  32. Dinarello, C. A., Bishai, I., Rosenwasser, L. J., & Coceani, F. (1984). The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1). International Journal of Immunopharmacology, 6, 43–50.CrossRefGoogle Scholar
  33. Dröge, W., Schulze-Osthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H. P., Roth, S., & Gmünder, H. (1994). Functions of glutathione and glutathione disulphide in immunology and immunopathology. FASEB Journal, 8, 1131–1138.Google Scholar
  34. Duncan, B. B., & Schmidt, M. I. (2001). Chronic activation of the innate immune system may underlie the metabolic syndrome. Sao Paulo Medical Journal, 119, 122–127.CrossRefGoogle Scholar
  35. Elia, M. (1992). Glutamine in parenteral nutrition. International Journal of Food Science and Nutrition, 43, 47–49.Google Scholar
  36. Emanuelli, B., Peraldi, P., & Filloux, C. (2001). SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. Journal of Biological Chemistry, 276, 47,944–47,949.Google Scholar
  37. Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., Schaefer, E. J., Wolff, S. M., & Dinarello, C. A. (1989). The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New England Journal of Medicine, 320, 265–271.CrossRefGoogle Scholar
  38. Ershler, W. B., & Kerller, E. T. (2000). Age-associated increased interleukin-6 gene expression, late diseases, and frailty. Annual Reviews of Medicine, 51, 245–270.CrossRefGoogle Scholar
  39. Espevik, T., Figari, I. S., Shalaby, M. R., Lackides, G. A., Lewis, G. D., Shepard, H. M., & Palladino, M. A., Jr. (1987). Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. Journal of Experimental Medicine, 166, 571–576.CrossRefGoogle Scholar
  40. Faggioni, R., Feingold, K. R., & Grunfeld, C. (2001). Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB Journal, 15, 2565–2571.CrossRefGoogle Scholar
  41. Fagiolo, U., Cossarizza, A., Scala, E., Fanales-Belasio, E., Ortolani, C., Cozzi, E., Monti, D., Franceschi, C., & Paganelli, R. (1993). Increased cytokine production in mononuclear cells of healthy elderly people. European Journal of Immunology, 23, 2375–2378.CrossRefGoogle Scholar
  42. Ferrucci, L, Harris, T. B., Guralnik, J. M., & Tracy, R. P. (1999). Serum IL-6 level and the development of disability in older persons. Journal of the American Geriatric Society, 47, 639–646.Google Scholar
  43. Festa, A., D’Agostino, R., Jr., & Williams, K. (2001). The relation of body fat mass and distribution to markers of chronic inflammation. International Journal of Obesity and Related Metabolic Disorders, 25, 1407–1415.CrossRefGoogle Scholar
  44. Folsom, A. R., Pankow, J. S., & Tracy, R. P. (2001). The Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. American Journal of Cardiology, 88, 112–117.CrossRefGoogle Scholar
  45. Formica, S., Roach, T. I., & Blackwell, J. M. (1994). Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release. Immunology, 82, 42–50.Google Scholar
  46. Forsberg, L., Lyrenas, L., de Faire, U., & Morgenstern, R. (2001). A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radical Biology and Medicine, 30, 500–505.CrossRefGoogle Scholar
  47. Franceschi, C., Motta, L., Valensin, S., Rapisarda, R., Franzone, A., Berardelli, M., Motta, M., Monti, D., Bonafe, M., Ferrucci, L., Deiana, L., Pes, G. M., Carru, C., Desole, M. S., Barbi, C., Sartoni, G., Gemelli, C., Lescai, F., Olivieri, F., Marchegiani, F., et al. (2000). Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano), 12, 77–84.Google Scholar
  48. Fruchart, J. C., Staels, B., & Duriez, P. (2001). PPARS, metabolic disease and atherosclerosis. Pharmacological Research, 44, 345–352.CrossRefGoogle Scholar
  49. Gadek, J. E., De Michele, S. J., Karlstad, M. D., Pacht, E. R., Donahoe, M., Albertson, T. E., Van Hoozen, C., Wennberg, A. K., Nelson, J. L., Nourselehi, M., & The Enteral Nutrition in ARDS Study Group. (1999). Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine, 27, 1409–1420.CrossRefGoogle Scholar
  50. Grau, A. J., Aulmann, M., Lichy, C., Meiser, H., Buggle, F., Brandt, T., & Grond-Ginsbach, C. (2001). Increased cytokine release by leucocytes in survivors of stroke at young age. European Journal of Clinical Investigation, 31, 999–1006.CrossRefGoogle Scholar
  51. Grimble, R. (1990). Serum albumin and mortality. Lancet, 1, 348.Google Scholar
  52. Grimble, R. F. (1996). Theory and efficacy of antioxidant therapy. Current Opinion in Critical Care, 2, 260–266.CrossRefGoogle Scholar
  53. Grimble, R. F. (1997). Effect of antioxidative vitamins on immune function with clinical applications. International Journal of Vitamin Nutrition Research, 67, 312–320.Google Scholar
  54. Grimble, R. F. (1998). Dietary lipids and the inflammatory response. Proceedings of the Nutrition Society, 57, 535–542.CrossRefGoogle Scholar
  55. Grimble, R. F. (2001a). Nutritional modulation of immune function. Proceedings of the Nutrition Society, 60, 389–397.CrossRefGoogle Scholar
  56. Grimble, R. (2001b). Stress proteins in disease: Metabolism on a knife edge. Clinical Nutrition, 20, 469–476.CrossRefGoogle Scholar
  57. Grimble, R. F. (2002). Inflammatory status and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care, 6, 21–29.CrossRefGoogle Scholar
  58. Grimble, R. F., Andersson, P., Madden, J., Palmblad, J., Persson, M., Vedin, I., & Cederholm, T. (2003). Gene:gene interactions influence the outcome in elderly patients. Clinical Nutrition, 22, S39.CrossRefGoogle Scholar
  59. Grimble, R. F., Howell, W. M., O’Reilly, G., Turner, S. J., Markovic, O., Hirrell, S., East, J. M., & Calder, P. C. (2002). The ability of fish oil to suppress tumor necrosis factor-alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes which influence TNF-alpha production. American Journal of Clinical Nutrition, 76, 454–459.Google Scholar
  60. Grimble, R. F., Thorell, A., Nygren, J., Ljungqvist, O., Barber, N., Grant, S., & Madden, J. (2003). Cytokine genotype and gender influence the inflammatory response to surgery. Clinical Nutrition, 22, S45.Google Scholar
  61. Hajeer, A. H., Lazarus, M., & Turner, D. (1998). IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scandinavian Journal of Rheumatology, 27, 142–145.CrossRefGoogle Scholar
  62. Hak, A. E., Pols, H. A., & Stehouwer, C. D. (2001). Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: The Rotterdam study. Journal of Clinical Endocrinology and Metabolism, 86, 4398–4405.CrossRefGoogle Scholar
  63. Han, S. N., Meydani, M., Wu, D., Bender, B. S., Smith, D. E., Vina, J., Cao, G. P., & Meydani, S. N. (2000). Effect of long-term dietary antioxidant supplementation on influenza virous infection. Journal of Gerontology Biological Sciences and Medical Sciences, 55, B496–503.Google Scholar
  64. Harris, T. B., Ferrucci, T., Tracy, R. P., & Corti, M. (1999). Associations between elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. American Journal of Medicine, 106, 506–512.CrossRefGoogle Scholar
  65. Hattori, S., Hattori, Y., Banba, N., Kasai, K., & Shimoda S. (1995). Pentamethyl-hydroxychromane, vitamin E derivative, inhibits induction of nitric oxide synthase by bacterial lipopolysaccharide. Biochemistry and Molecular Biology International, 35, 177–183.Google Scholar
  66. Hegazy, D. M., O’Reilly, D. A., & Yang, B. M. (2001). NFkappaB polymorphisms and susceptibility to type 1 diabetes. Genes and Immunology, 2, 304–308.CrossRefGoogle Scholar
  67. Hotamisligil, G. S., Budavari, A., Murray, D., & Spiegelman, B. M. I. (1994). Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Journal of Clinical Investigation, 94, 1543–1549.Google Scholar
  68. Hotamisligil, G. S., Peraldi. P., Budavari. A., Ellis, R., White, M. F., & Spiegelman, B. M. I. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science, 271, 665–668.CrossRefGoogle Scholar
  69. Hotamisligil, G. S., & Spiegelman, B. M. I. (1994). Tumor necrosis factor a: A key component of the obesity-diabetes link. Diabetes, 43, 1271–1278.CrossRefGoogle Scholar
  70. Houdijk, A. P. J., Rijnsburger, E. R., Jansen, J., Wesdorp, R. I. C., Weiss, J. K., McCamish, M. A., Teerlink, T., Meuwissen, S. G. M., Haarman, H. J. ThM., Thijs, L. G., & Van Leeuwen, P. A. M. (1998). Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet, 352, 772–776.CrossRefGoogle Scholar
  71. Huang, Y. C., Guh, J. H., Cheng, Z. J., Chang, Y. L., Hwang, T. L., Liao, C. H., Tzeng, C. H., & Teng, C. M. (2001). Inhibition of the expression of inducible nitric oxide synthase and cyclooxygenase-2 in macrophages in macrophages by & HQ derivatives: Involvement of IkappaB-alpha stabilisation. European Journal of Pharmacology, 418, 133–139.CrossRefGoogle Scholar
  72. Huizinga, T. W., Keijsers, V., & Yanni, G. (2002). Are differences in interleukin 10 production associated with joint damage? Rheumatology, 39, 1180–1188.CrossRefGoogle Scholar
  73. Hunter, E. A. L., & Grimble, R. F. (1994). Cysteine and methionine supplementation modulate the effect of tumor necrosis factor α on protein synthesis, glutathione and zinc content of tissues in rats fed a low-protein diet. Journal of Nutrition, 124, 2319–2328.Google Scholar
  74. Hutchinson, I. V., Pravica, V., Hajeer, A., & Sinnott, P. J. (1999). Identification of high and low responders to allographs. Review in Immunogenetics, 1, 323–333.Google Scholar
  75. Iwamoto, Y., Nishimura, F., & Nakagawa, M. (2001). The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. Journal of Periodontolology, 72, 774–778.CrossRefGoogle Scholar
  76. Jacob, C. O., Franek, Z., Lewis, G. D., Koo, M., Hansen, J. A., & McDevitt, H. O. (1990). Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor-α: Relevance to genetic predisposition to systemic lupus erythematosus. Proceedings of the National Academy of Science, 87, 1233–1237.CrossRefGoogle Scholar
  77. Jacob, R. A., Kelley, D. S., Pianalto, F. S., Swendseid, M. E., Henning, S. M., Zhang, J. Z., Ames, B. N. Fraga, C. G., & Peters, J. H. (1991). Immunocompetence and oxidant defense during ascorbate depletion of healthy men. American Journal of Clinical Nutrition, 54, 1302S–1309S.Google Scholar
  78. Jersmann, H. P., Hii, C. S., Ferrante, J. V., & Ferrante, A. (2001). Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways. Infection and Immunology, 69, 1273–1279.CrossRefGoogle Scholar
  79. Jialal, I., Fuller, C. J., & Huet, B. A. (1995). The effect of alpha-tocopherol supplementation on LDL oxidation. Arteriosclerosis, Thrombosis and Vascular Biology, 15, 190–198.Google Scholar
  80. Jonkers, I. J., Mohrschladt, M. F., & Westendorp. R. G. (2002). Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: Reversal with bezafibrate therapy in a randomized controlled trial. American Journal of Medicine, 112, 275–280.CrossRefGoogle Scholar
  81. Kol, A., Sukhova, G. K., Lichtman, A. H., & Libby, P. (1998). Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-a andmatrix metalloproteinase expression. Circulation, 98, 300–307.Google Scholar
  82. Kovarova, H., Necasova, R., Porkertova, S., Radzioch, D., & Macela, A. (2001). A Natural resistance to intracellular pathogens: Modulation of macrophage signal transduction related to the expression of the Bcg locus. Proteomics, 1, 587–596.CrossRefGoogle Scholar
  83. Kudoh, A., Katagai, H., Takazawa, T., & Matsuki, A. (2001). Plasma proinflammatory cytokine response to surgical stress in elderly patients. Cytokine, 15, 270–273.CrossRefGoogle Scholar
  84. Kunkel, S. L., Remick, D. G., Spengler, M., & Chensue, S. W. (1987). Modulation of macrophage-derived interleukin-1 and tumour necrosis factor by prostaglandin E2. Advances in Prostaglandin, Leukotriene and Thromboxane Research, 17A, 155–156.Google Scholar
  85. Lio, D., Scola, L., Crivello, A., Bonafe, M., Franceschi, C., Olivieri, F., Colonna Romano, G., Candore, G., & Caruso, C. (2002). Allele frequencies of +874TgA single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Experimental Gerontolology, 37, 315–319.CrossRefGoogle Scholar
  86. Loguercio, C., Blanco, F. D., De Girolamo, V., Disalvo, D., Nardi, G., Parente, A., & Blanco, C. D. (1999). Ethanol consumption, amino acid and glutathione blood levels in patients with and without chronic liver disease. Alcohol Clinical and Experimental Research, 23, 1780–1784.Google Scholar
  87. Luo, J. L., Hammarqvist, F., Andersson, K., & Wernerman, J. (1996). Skeletal muscle glutathione after surgical trauma. Annals of Surgery, 223, 420–427.CrossRefGoogle Scholar
  88. Martin, G. M. (1997). Genetics and the pathobiology of ageing. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 352, 1773–1780.CrossRefGoogle Scholar
  89. Marwick, C. (1997). NHANES III health data relevant for aging nation. Journal of the American Medical Association, 277, 100–102.CrossRefGoogle Scholar
  90. McGuire, W., Hill, A. V., Allsopp, C. E., Greenwood, B. M. & Kwiatkowski, D. (1994). Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature, 371, 508–510.CrossRefGoogle Scholar
  91. Messer, G., Spengler, U., Jung, M. C., Honold, G., Blomer, K., Pape, G. R., Riethmuller, G., & Weiss, E. H. (1991). Polymorphic structure of the tumour necrosis factor (TNF) locus: An Nco I polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNFα production. Journal of Experimental Medicine, 173, 209–219.CrossRefGoogle Scholar
  92. Meydani, S. N., Barklund, P. M., & Liu, S. (1990). Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. American Journal of Clinical Nutrition, 52, 557–563.Google Scholar
  93. Meydani, S. N., Endres, S., & Woods, M. N. (1991). Oral (n-3) fatty acid supplementation supresses cytokine production and lymphocyte proliferation: Comparison between young and older women. Journal of Nutrition, 121, 547–555.Google Scholar
  94. Meydani, S. N., Lichenstein, A. H., & Cornwall, S. (1993). Immunological effects of national cholesterol education panel (NCEP) step-2 diets with and without fish-derived (n-3) fatty acid enrichment. Journal of Clinical Investigation, 92, 105–113.Google Scholar
  95. Meydani, S. N., Meydani, M., Blumberg, J. B., Leka, L. S., Silber, G., Loszewski, R., Thompson, C., Pedrosa, R. D., Diamond, D., & Stoller, D. (1997). Vitamin E supplementation and in vivo immune response in healthy subjects. A randomized controlled trial. Journal of the American Medical Association, 277, 1370–1386.CrossRefGoogle Scholar
  96. Meydani, S. N., Meydani, M., & Verdon, C. P. (1986). Vitamin E supplementation suppresses prostaglandin E2 synthesis and enhances the immune response of aged mice. Mechanisms of Ageing and Development, 34, 191–201.CrossRefGoogle Scholar
  97. Micke, P., Beeh, K. M., Schlaak, J. F., & Buhl, R. (2001). Oral supplementation with whey proteins increases plasma glutathione levels in HIV-infected patients. European Journal of Clinical Investigation, 31, 171–178.CrossRefGoogle Scholar
  98. Mira, J. P., Cariou, A., Grall, F., Delclaux, C., Losser, M. R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J. L., Riche, F., Leleu, G., Arbibe, L., Mignon, A., Delpech, M., & Dhainaut, J. F. (1999). Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. Journal of the American Medical Association, 282, 561–568.CrossRefGoogle Scholar
  99. Mitrunen, K., Sillanpaa, P., Kataja, V., Eskelinen, M., Kosma, V. M., Benhamou, S., Uusitupa, M., & Hirvonen, A. (2001). Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis, 22, 827–829.CrossRefGoogle Scholar
  100. Mol, J. T. M., de Rijke, Y. B., Demacher, P. M. N., & Stalenhoef, A. F. H. (1997). Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and smokers: Effect of vitamin E treatment. Atherosclerosis, 129, 169–176.CrossRefGoogle Scholar
  101. Moller, D. E. (2000). Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinology Metabolism, 11, 212–217.CrossRefGoogle Scholar
  102. Momoi, A., Murao, K., & Imachi, H. (2001). Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione. Chest, 120, 1293–1300.CrossRefGoogle Scholar
  103. Morlion, B. J., Stehle, P., Wachtler, P., Siedhoff, H-P., Koller, M., Konig, W., Furst, P., & Puchstein, C. (1998). Total parenteral nutrition with glutamine dipeptide after major surgery. A double blind controlled study. Annals of Surgery, 227, 302–308.CrossRefGoogle Scholar
  104. Munro, R., & Capell, H. (1997). Prevalence of low body mass in rheumatoid arthritis: Association with the acute phase response. Annals of Rheumatic Disease, 56, 326–369.Google Scholar
  105. Mysliwska, J., Bryl, E., Foerster, A., & Mysliwski, A. (1998). Increase in IL-6 and decrease of interleukin 2 production during the ageing process are influenced by health status. Mechanisms of Ageing and Development, 100, 313–328.CrossRefGoogle Scholar
  106. Newsholme, E. A., Crabtree, B., Salleh, M., & Ardawi, M. (1985). Glutamine metabolism in lymphocytes. Its biochemistry, physiology and clinical importance. Quarterly Journal of Experimental Physiology, 70, 473–489.Google Scholar
  107. Nilsson, J., Jovinge, S., Niemann, A., Reneland, R., & Lithell, H. (1998). Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arteriosclerosis, Thrombosis and Vascular Biology, 18, 1199–1202.Google Scholar
  108. Nishimura, F., & Murayama, Y. (2001). Periodontal inflammation and insulin resistance—lessons from obesity. Journal of Dental Research, 80, 1690–1694.Google Scholar
  109. Nuttall, S. L., Dunne, F., Kendall, M. J., & Martin, U. (1999). Age-dependent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus. Quarterly Journal of Medicine, 92, 33–38.Google Scholar
  110. Onat, A., Sansoy, V., & Yildirim, B. (2001). C-reactive protein and coronary heart disease in western Turkey. American Journal of Cardiology, 88, 601–607.CrossRefGoogle Scholar
  111. Ono, S., Aosasa, S., Tsujimoto, H., Ueno, C., & Mochizuki, H. (2001). Increased monocyte activation in elderly patients after surgical stress. European Journal of Surgical Research, 33, 33–38.CrossRefGoogle Scholar
  112. Pannacciulli, N., Cantatore, F. P., & Minenna, A. (2001). C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International Journal of Obesity and Related Metabolic Disorders, 25, 1416–1420.CrossRefGoogle Scholar
  113. Paolini-Giacobino, A. A., Grimble, R., & Pichard, C. (2003). Genomic interactions with disease and nutrition. Clinical Nutrition, 22, 507–514.CrossRefGoogle Scholar
  114. Pena, L. R., Hill, D. B., & McClain, C. J. (1999). Treatment with glutathione precursor decreases cytokine activity. Journal of Parenteral and Enteral Nutrition, 23, 1–6.Google Scholar
  115. Perrey, C., Pravica, V., Sinnott, P. J., & Hutchinson, I. V. (1998). Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transplantation Immunology, 6, 193–197.CrossRefGoogle Scholar
  116. Pfeilschifter, J., Koditz, R., Pfohl, M., & Schatz, H. (2002). Changes in proinflammatory cytokine activity after menopause. Endocrinological Reviews, 23, 90–119.CrossRefGoogle Scholar
  117. Pradhan, A. D., Manson, J. E., Rifai, N. (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association, 286, 327–334.CrossRefGoogle Scholar
  118. Prio, T. K., Bruunsgaard, H., Roge, B., & Pedersen, B. K. (2002). Asymptomatic bacteriuria in elderly humans is associated with increased levels of circulating TNF receptors and elevated numbers of neutrophils. Experimental Gerontology, 37, 693–699.CrossRefGoogle Scholar
  119. Reid, C. L., Hutchinson, I. V., Campbell, I. T., & Little, R. A. (1999). Genetic variation in cytokine production may be protective of ICU admission and may influence mortality. Clinical Nutrition, 18, 45.Google Scholar
  120. Reid. M., Badaloo, A., Forrester, T., Morlese, J. F., Frazer, M., Heird, W. C., & Jahoor, F. (2000). In vivo rates of erythrocyte glutathione synthesis in children with severe protein-energy malnutrition. American Journal of Physiology, 278, E405–412.Google Scholar
  121. Rink, L., Cakman, I., & Kirchner, H. (1998). Altered cytokine production in the elderly. Mechanisms of Ageing and Development, 102, 199–209.CrossRefGoogle Scholar
  122. Robinson, M. K., Rodrick, M. L., Jacobs, D. O., Rounds, J. D., Collins, K. H., Saporoschetz, I. B., Mannick, J. A., & Wilmore, D. W. (1993). Glutathione depletion in rats impairs T-cell and macrophage immune function. Archives of Surgery, 128, 29–34.Google Scholar
  123. Rohleder, N., Kudielka, B. M., Hellhammer, D. H., Wolf, J. M., & Kirschbaum, C. (2002). Age and sex steroid-related changes in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Journal of Neuroimmunology, 126, 69–77.CrossRefGoogle Scholar
  124. Romano, M., Pomilio, M., & Vigneri, S. (2001). Endothelial perturbation in children and adolescents with type 1 diabetes: Association with markers of the inflammatory reaction. Diabetes Care, 24, 1674–1678.CrossRefGoogle Scholar
  125. Rosenberg, I. H. (1989). Epidemiologic and methodologic problems in determining nutritional status of older persons. American Journal of Clinical Nutrition, 50 (Suppl.), 1231–1233.Google Scholar
  126. Ross, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature, 362, 801–809.CrossRefGoogle Scholar
  127. Roubenoff, R. (2001). Origins and clinical relevance of sarcopenia. Canadian Journal of Applied Physiology, 26, 78–89.Google Scholar
  128. Sakao, S., Tatsumi, K., Igari, H., Shino, Y., Shirasawa, H., & Kuriyama, T. (2001). Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. American Journal of Respiratory and Cirtical Care Medicine, 163, 420–422.Google Scholar
  129. Saldeen, T. G., & Rand, K. (1998). Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. Journal of the American College of Cardiology, 31, 1217–1225.CrossRefGoogle Scholar
  130. Schreck, R., Rieber, P., & Baeurerle, P. A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of nuclear transcription factor-κB and HIV-1. EMBO Journal, 10, 2247–2256.Google Scholar
  131. Schaaf, B. M., Seitzer, U., Pravica, V., Aries, S. P., & Zabel, P. (2001). Tumor necrosis factor-alpha —308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer’s lung patients. American Journal of Respiratory and Critical Care Medicine, 163, 379–382.Google Scholar
  132. Schroder, J., Kahlke, V., Book, M., & Stuber, F. (2000). Gender differences in sepsis: Genetically determined? Shock, 14, 307–310.Google Scholar
  133. Searle, S., & Blackwell, J. M. (1999). Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. Journal of Medical Genetics, 36, 295–299.Google Scholar
  134. Shurtz-Swirski, R., Sela, S., & Herskovits, A. T. (2001). Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care, 24, 104–110.CrossRefGoogle Scholar
  135. Spapen, H., Zhang, H., Demanet, C., Vleminckx, W., Vincent, J.L., & Huyghens, L. (1998). Does N-acetyl cysteine inflkuence cytokine response during early human septic shock? Chest, 113, 1616–1624.Google Scholar
  136. Spitzer, J. J., Bagby, G. J., Meszaros, K., & Lang, C. H. (1988). Alterations in lipid and carbohydrate metabolism in sepsis. Journal of Parenteral and Enteral Nutrition, 12 (Suppl.), 53S–58S.CrossRefGoogle Scholar
  137. Spitzer, J. J., Bagby, G. J., Meszaros, K., & Lang, C. H. (1989). Altered control of carbohydrate metabolism in endotoxemia. Progress in Clinical and Biological Research, 286, 145–165.Google Scholar
  138. Staal, F. J. T., Ela, S. W., & Roederer, M. (1992). Glutathione deficiency in human immunodeficiency virus infection. Lancet, i, 909–912.CrossRefGoogle Scholar
  139. Steiner, M. (1999). Vitamin E, a modifier of platelet function: Rationale and use in cardiovascular and cerebrovascular disease. Nutrition Reviews, 57, 306–309.CrossRefGoogle Scholar
  140. Stuber, F., Petersen, M., Bokelmann, F., & Schade, U. (1996). A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Critical Care Medicine, 24, 381–384.CrossRefGoogle Scholar
  141. Tagore, A., Gonsalkorale, W. W., & Pravica, V. (1999). Interleukin 10 (IL-10) genotypes in inflammatory bowel disease. Tissues Antigens, 54, 386–390.CrossRefGoogle Scholar
  142. Taniguchi, T., Koido, Y., Aiboshi, J., Yamashita, T., Suzaki, S., & Kurokawa, A. (1999). Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Critical Care Medicine, 27, 1262–1264.CrossRefGoogle Scholar
  143. Tanus-Santos, J. E., Desai, M., Deak, L. R., Pezzullo, J. C., Abernethy, D. R., Flockhart, D. A., & Freedman, J. E. (2002). Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics, 12, 407–413.CrossRefGoogle Scholar
  144. Turner, D. M., Williams, D. M., & Sankaran, D. (1997). An investigation of polymorphisms in the interleukin-10 gene promoter. European Journal of Immunogenetics, 24, 108–116.Google Scholar
  145. van Dissel, J. T., van Langevelde, P., Westendorp, R. G., Kwappenberg, K., & Frolich, M. (1998). Antiinflammatory cytokine profile and mortality in febrile patients. Lancet, 351, 950–955.Google Scholar
  146. van Tits, L. J., Demacker, P. N., de Graaf, J., Hak-Lemmers, H. L., & Stalenhoef, A. F. (2000). Alphatocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. American Journal of Clinical Nutrition, 71, 458–464.Google Scholar
  147. Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002). Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. Journal of Gerontology Biological Science and Medical Science, 57, M326–332.Google Scholar
  148. Vozarova, B., Weyer, C., & Hanson, K. (2001). Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research, 9, 414–417.Google Scholar
  149. Vozarova, B., Weyer, C., & Lindsay, R. S. (2002). High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes, 51, 455–461.CrossRefGoogle Scholar
  150. Wada, K., Nakajima, A., & Blumberg, R. S. (2001). PPAR-gamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn’s disease. Trends in Molecular Medicine, 7, 329–331.CrossRefGoogle Scholar
  151. Wang, X. Y., Hurme, M., Jylha, M., & Hervonen, A. (2001). Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mechanisms of Ageing and Development, 123, 29–38.CrossRefGoogle Scholar
  152. Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998). Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood, 91, 3574–3581.Google Scholar
  153. Wesselborg, S., Bauer, M. K. A., Vogt, M., Schmitz, M. L., & Schulze-Osthoff, K. (1997). Activation of transcription factor NF-kappa B and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. Journal of Biological Chemistry, 272, 12,422–12,429.CrossRefGoogle Scholar
  154. Weyer, C., Yudkin, J. S., & Stehouwer, C. D. (2002). Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis, 161, 233–242.CrossRefGoogle Scholar
  155. Willeit, J., & Kiechl, S. (2000). Biology of arterial atheroma. Cerebrovascular Disease. 10(Suppl. 5), 1–8.CrossRefGoogle Scholar
  156. Wilson, A. G., Clay, F. E., & Crane, A. M. (1995). Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis. Journal of Investigative Dermatology, 104, 856–858.CrossRefGoogle Scholar
  157. Wilson, A. G., de Vries, N., Pociot, F., di Giovine, F. S., van der Putte, L. B., & Duff, G. W. (1993). An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA-A1, B8, and DR3 alleles. Journal of Experimental Medicine, 177, 557–560.CrossRefGoogle Scholar
  158. Wilson, A. G., Gordon, C., & di Giovine, F. S. (1994). A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. European Journal of Immunology, 24, 191–195.CrossRefGoogle Scholar
  159. Wu, D., Koga, T., Martin, K. R., & Meydani, M. (1999). Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis, 147, 297–307.CrossRefGoogle Scholar
  160. Wu, D., Meydani, S. N., & Han, S. N. (2000). Effect of dietary supplementation with fish oil in combination with different levels of vitamin E on immune response in healthy elderly human subjects. FASEB. Journal, 14, A238.Google Scholar
  161. Wu, D., Meydani, S. N., Sastre, J., Hayek, M., & Meydani, M. (1994). In vitro glutathione supplementation enhances interleukin-2 production and mitogenic responses in peripheral blood mononuclear cells from young and old subjects. Journal of Nutrition, 124, 655–663.Google Scholar
  162. Wu, T., Dorn, J. P., & Donahue, R. P. (2002). Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: The Third National Health and Nutrition Examination Survey, 1988–1994. American Journal of Epidemiology, 155, 65–71.CrossRefGoogle Scholar
  163. Yaqoob, P., Newsholme, E. A., & Calder, P.C. (1999). Production of tumour necrosis factor—alpha increases with age and BMI in healthy women. Proceedings of the Nutrition Society, 58, 129A.Google Scholar
  164. Young, D. G., Skibinski, G., Mason, J. I., & James, K. (1999). The influence of age and gender on serum dehydroepiaandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta 1) levels in normal healthy blood donors. Clinical and Experimental Immunology, 117, 476–481.CrossRefGoogle Scholar
  165. Zhai, R., Jetten, M., Schins, R. P., Franssen, H., & Borm, P. J. (1998). Polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners. American Journal of Industrial Medicine, 34, 318–324.CrossRefGoogle Scholar
  166. Ziccardi, P., Nappo, F., & Giugliano, G. (2002). Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation, 105, 804–809.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Robert F. Grimble
    • 1
  1. 1.Institute of Human NutritionUniversity of SouthamptonSouthamptonUK

Personalised recommendations